摘要
近年来应用胎肝移植治疗白血病、重度再生障碍性贫血、晚期淋巴瘤均取得良好的疗效,在一定程度上替代了骨髓移植。本文报道8例晚期恶性淋巴瘤胎肝移植的长期随访结果,试与自身骨髓移植治疗晚期淋巴瘤组相比较,分析影响生存的各种因素,为今后选择病例和改进预处理方案提供依据。
Eight patients with advanced lymphoma were treated from 1985 to 1988 by one dose of cyclophosphamide, irradiation (TLI or TBI) and human fetal liver infusion. The clinical results showed that the 3 year and 5 year survival rates were 50% and 25%, respectively. WBC and platelet count recovered after treatment. The long-term survival of human fetal liver infusion was not significantly different from that of autologous bone marrow transplantation. The human fetal liver infusion method was simple, safe and convenient. The authors suggest that this method may play an important role in the treatment of advanced lymphomas.
出处
《中华放射肿瘤学杂志》
CSCD
1990年第4期33-35,共3页
Chinese Journal of Radiation Oncology
